dideoxyadenosine
Term · Oncology and biomedicine · MLC-T-ONC-013044
A synthetic nucleoside analogue of deoxyadenosine and a prodrug of didanosine in which the 3' hydroxyl group on the ribose moiety is replaced by a hydrogen atom. Dideoxyadenosine competitively inhibits adenylyl cyclase, thereby reducing levels of cyclic adenosine monophosphate (cAMP). By inhibiting cAMP-mediated gene activation in tumor cells, this agent may retard tumor cell proliferation.
| Identifier | MLC-T-ONC-013044 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | ddA |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013044",
"term": "dideoxyadenosine",
"field": "Oncology and biomedicine",
"definition": "A synthetic nucleoside analogue of deoxyadenosine and a prodrug of didanosine in which the 3' hydroxyl group on the ribose moiety is replaced by a hydrogen atom. Dideoxyadenosine competitively inhibits adenylyl cyclase, thereby reducing levels of cyclic adenosine monophosphate (cAMP). By inhibiting cAMP-mediated gene activation in tumor cells, this agent may retard tumor cell proliferation.",
"abbreviation": "ddA",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/dideoxyadenosine/"
}
Record 5,966 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.